Clinical trial
An International, Multicentre, Non-comparative, Non-interventional, Prospective Clinical Registry to Evaluate the Clinical Outcome and Safety of the Treatment of Severely Infected Patients with Fosfomycin I.v.
NCT02979951 is registered in ClinicalTrials.gov with Infectopharm Arzneimittel GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An International, Multicentre, Non-comparative, Non-interventional, Prospective Clinical Registry to Evaluate the Clinical Outcome and Safety of the Treatment of Severely Infected Patients with Fosfomycin I.v.
- Lead sponsor
- Infectopharm Arzneimittel GmbH
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 31, 2016
- Completion date
- December 31, 2030
- Enrollment
- 1,000 (estimated)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.
bacteremia, bacterial infections, bone diseases, infectious, brain abscess, central nervous system bacterial infections, encephalitis, endocarditis, bacterial, intraabdominal infections, meningitis, bacterial, osteomyelitis, pneumonia, bacterial, respiratory tract infections, sepsis, skin diseases, bacterial, soft tissue infections, urinary tract infections